Business Description
Vector Science and Therapeutics Corp
NAICS : 339110
SIC : 3912
ISIN : CA92244M1041
Description
Vector Science and Therapeutics Corp develops novel biomechanical devices and active transdermal drug and peptide delivery platforms to equip clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.43 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.2 | |||||
9-Day RSI | 25.45 | |||||
14-Day RSI | 33.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 20.79 | |||||
Quick Ratio | 20.79 | |||||
Cash Ratio | 11.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -108.71 | |||||
ROA % | -53.99 | |||||
ROIC % | -379.3 | |||||
ROC (Joel Greenblatt) % | -468.7 | |||||
ROCE % | -57.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 8.75 | |||||
Price-to-Tangible-Book | 9.12 | |||||
EV-to-EBIT | -4.38 | |||||
EV-to-EBITDA | -4.4 | |||||
EV-to-FCF | -2.67 | |||||
| Price-to-Net-Current-Asset-Value | 10.33 | |||||
Earnings Yield (Greenblatt) % | -22.83 | |||||
FCF Yield % | -33.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vector Science and Therapeutics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.312 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 33.56 | ||
| 14-Day ATR (C$) | 0.184488 | ||
| 20-Day SMA (C$) | 2.1765 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (C$) | 0.35 - 2.65 | ||
| Shares Outstanding (Mil) | 5.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vector Science and Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vector Science and Therapeutics Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vector Science and Therapeutics Corp Frequently Asked Questions
What is Vector Science and Therapeutics Corp(TSXV:PAIN)'s stock price today?
The current price of TSXV:PAIN is C$1.55. The 52 week high of TSXV:PAIN is C$2.65 and 52 week low is C$0.35.
When is next earnings date of Vector Science and Therapeutics Corp(TSXV:PAIN)?
The next earnings date of Vector Science and Therapeutics Corp(TSXV:PAIN) is .
Does Vector Science and Therapeutics Corp(TSXV:PAIN) pay dividends? If so, how much?
Vector Science and Therapeutics Corp(TSXV:PAIN) does not pay dividend.
Press Release
Articles on Vector Science and Therapeutics Corp
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers